Striatal dopamine in P arkinson disease: a meta‐analysis of imaging studies
V Kaasinen, T Vahlberg - Annals of neurology, 2017 - Wiley Online Library
A meta‐analysis of 142 positron emission tomography and single photon emission computed
tomography studies that have investigated striatal presynaptic dopamine function in …
tomography studies that have investigated striatal presynaptic dopamine function in …
Dopamine receptors in Parkinson's disease: a meta‐analysis of imaging studies
V Kaasinen, T Vahlberg, AJ Stoessl… - Movement …, 2021 - Wiley Online Library
Dopamine receptors are abundant along the central nigrostriatal tract and are expressed as
5 subtypes in two receptor families. In PD, compensatory changes in dopamine receptors …
5 subtypes in two receptor families. In PD, compensatory changes in dopamine receptors …
[HTML][HTML] Mortality and cause of death in hip fracture patients aged 65 or older-a population-based study
…, VM Mattila, P Jaatinen, T Vahlberg… - BMC musculoskeletal …, 2011 - Springer
Background The high mortality of hip fracture patients is well documented, but sex- and
cause-specific mortality after hip fracture has not been extensively studied. The purpose of the …
cause-specific mortality after hip fracture has not been extensively studied. The purpose of the …
Investigating minimal clinically important difference for Constant score in patients undergoing rotator cuff surgery
J Kukkonen, T Kauko, T Vahlberg, A Joukainen… - Journal of shoulder and …, 2013 - Elsevier
Background The minimal clinically important difference (MCID) is increasingly used to
evaluate treatment effectiveness. The MCID for the Constant score has not been previously …
evaluate treatment effectiveness. The MCID for the Constant score has not been previously …
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
…, TJ Airaksinen, M Niemelä, T Vahlberg… - European heart …, 2007 - academic.oup.com
Aim The aim of this study was to evaluate the antithrombotic treatment adopted after coronary
stenting in patients requiring long-term anticoagulation. Methods and results We analysed …
stenting in patients requiring long-term anticoagulation. Methods and results We analysed …
Diagnosing cognitive impairment and dementia in primary health care–a more active approach is needed
M Löppönen, I Räihä, R Isoaho, T Vahlberg… - Age and …, 2003 - academic.oup.com
Objective: to determine the documentation rate of dementia in primary health care, the
clinical characteristics of patients with documented and undocumented dementia, and the …
clinical characteristics of patients with documented and undocumented dementia, and the …
Attached to the web—harmful use of the Internet and its correlates
…, S Kaarlas, M Jääskeläinen, T Vahlberg… - European …, 2010 - cambridge.org
Background and aimsThe aim of this study was to test the validity of the Finnish version of
the Internet Addiction Test and the correlates of harmful use of the Internet.MethodsOne …
the Internet Addiction Test and the correlates of harmful use of the Internet.MethodsOne …
[HTML][HTML] Self-rated health and objective health status as predictors of all-cause mortality among older people: a prospective study with a 5-, 10-, and 27-year follow-up
M Wuorela, S Lavonius, M Salminen, T Vahlberg… - BMC geriatrics, 2020 - Springer
Background Despite a non-specific nature of self-rated health (SRH), it seems to be a strong
predictor of mortality. The aim of this study is to assess the association of SRH and objective …
predictor of mortality. The aim of this study is to assess the association of SRH and objective …
[PDF][PDF] Incidence and mortality of neurofibromatosis: a total population study in Finland
…, S Suominen, J Vahtera, T Vahlberg… - The Journal of …, 2015 - academia.edu
2005; Evans et al., 2010; Supplementary Table S1 online). NF2 is markedly less common
than NF1. The reported incidences of NF2 have varied between 1/33,000 (Evans et al., 2010) …
than NF1. The reported incidences of NF2 have varied between 1/33,000 (Evans et al., 2010) …
Early oseltamivir treatment of influenza in children 1–3 years of age: a randomized controlled trial
…, P Lehtinen, R Vainionpää, T Vahlberg… - Clinical infectious …, 2010 - academic.oup.com
Background. Oseltamivir provides modest clinical benefits to children with influenza when
started within 48 hours of symptom onset. The effectiveness of oseltamivir could be …
started within 48 hours of symptom onset. The effectiveness of oseltamivir could be …